Ethyl-Icosapent ( DrugBank: Icosapent )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 8 | ハンチントン病 | 4 |
8. ハンチントン病
臨床試験数 : 229 / 薬物数 : 193 - (DrugBank : 60) / 標的遺伝子数 : 84 - 標的パスウェイ数 : 158
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2005-002088-98-PT (EUCTR) | 07/06/2006 | 16/03/2006 | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | HUNTINGTON’S DISEASE MedDRA version: 8.0;Level: LLT;Classification code 10010331 | Product Name: Ethyl-EPA Product Code: LAX-101 INN or Proposed INN: Ethyl Icosapent Other descriptive name: Ethyl-EPA | Amarin Neuroscience Ltd | NULL | Not Recruiting | Female: yes Male: yes | Portugal;Germany;United Kingdom;Spain;Italy | ||||
| 2 | EUCTR2005-002088-98-AT (EUCTR) | 01/12/2005 | 27/10/2005 | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | HUNTINGTON’S DISEASE MedDRA version: 8.0;Level: LLT;Classification code 10010331 | Product Name: Ethyl-EPA Product Code: LAX-101 INN or Proposed INN: Ethyl-Icosapent | Amarin Neuroscience Ltd | NULL | Not Recruiting | Female: yes Male: yes | 240 | Portugal;Spain;Austria;Germany;Italy;United Kingdom | |||
| 3 | EUCTR2005-002088-98-GB (EUCTR) | 07/11/2005 | 18/08/2005 | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | HUNTINGTON’S DISEASE MedDRA version: 8.0;Level: LLT;Classification code 10010331 | Product Name: Ethyl-EPA Product Code: LAX-101 | Amarin Neuroscience Ltd | NULL | Not Recruiting | Female: yes Male: yes | Portugal;Germany;United Kingdom;Spain;Italy | ||||
| 4 | EUCTR2005-002088-98-DE (EUCTR) | 28/11/2006 | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease | HUNTINGTON’S DISEASE MedDRA version: 8.0;Level: LLT;Classification code 10010331 | Product Name: Ethyl-EPA Product Code: LAX-101 INN or Proposed INN: Ethyl-Icosapent | Amarin Neuroscience Ltd | NULL | Not Recruiting | Female: yes Male: yes | 240 | Portugal;United Kingdom;Germany;Spain;Italy |